Xenetic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. 

CEO
James F. Parslow
CEOJames F. Parslow
Employees
2
Employees2
Headquarters
Framingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded
2011
Founded2011
Employees
2
Employees2

XBIO Key Statistics

Market cap
5.64M
Market cap5.64M
Price-Earnings ratio
-1.55
Price-Earnings ratio-1.55
Dividend yield
Dividend yield
Average volume
35.31K
Average volume35.31K
High today
$3.76
High today$3.76
Low today
$3.61
Low today$3.61
Open price
$3.65
Open price$3.65
Volume
14.38K
Volume14.38K
52 Week high
$5.27
52 Week high$5.27
52 Week low
$2.20
52 Week low$2.20

People also own

Based on the portfolios of people who own XBIO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.